PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32528527-10	2020	In the absence of metabolic disturbances, 4-week PEP containing PI plus AZT + 3TC led to higher mitochondrial toxicity (-17.9 +- 25.8 decrease in mtDNA/nDNA levels) than PI plus TDF + FTC (which increased by 43.2 +- 24.3 units mtDNA/nDNA; p < 0.05 between groups).	Lamivudine	78-81	prolyl endopeptidase	Homo sapiens	49-52	
26559816-9	2015	Seventy-eight percent (n = 2772) of patients received a prescription for PEP, consisting of Tenofovir/Emtracitabine (TVD) + Lopinavir/Ritonavir (LPV) in 74% of cases, followed by Zidovudine/Lamivudine (CBV) + LPV (10%) and TVD + Raltegravir (RAL) (8%).	Lamivudine	190-200	prolyl endopeptidase	Homo sapiens	73-76	
31291899-10	2019	Genotyping and treatment sensitivity performed on sample after one month of PrEP showed a virus resistance to lamivudine and emtricitabine.	Lamivudine	110-120	prolyl endopeptidase	Homo sapiens	76-80	
14766370-3	2004	We chose to evaluate immunologic function in HIV negative patients who received Nelfinavir and Combivir (AZT and 3TC) as PEP.	Lamivudine	113-116	prolyl endopeptidase	Homo sapiens	121-124